Edwards Lifesciences Corporation Stock price
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
95.56 USD | +0.43% | +0.93% | +25.32% |
Mar. 27 | North American Morning Briefing : Stocks Edge -2- | DJ |
Mar. 26 | Edwards Lifesciences Longtime Chair To Retire | DJ |
Financials (USD)
Sales 2024 * | 6.52B | Sales 2025 * | 7.17B | Capitalization | 57.27B |
---|---|---|---|---|---|
Net income 2024 * | 1.62B | Net income 2025 * | 1.82B | EV / Sales 2024 * | 8.49 x |
Net cash position 2024 * | 1.95B | Net cash position 2025 * | 3.19B | EV / Sales 2025 * | 7.54 x |
P/E ratio 2024 * |
35.5
x | P/E ratio 2025 * |
31.7
x | Employees | 19,800 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.52% |
Latest transcript on Edwards Lifesciences Corporation
1 day | +1.85% | ||
1 week | +2.27% | ||
Current month | +12.11% | ||
1 month | +9.99% | ||
3 months | +24.85% | ||
6 months | +35.72% | ||
Current year | +24.79% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 14-12-31 | |
Chairman | 71 | 99-12-31 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Leslie Heisz
BRD | Director/Board Member | 63 | 16-07-04 |
Director/Board Member | 67 | 14-11-12 | |
Steven Loranger
BRD | Director/Board Member | 72 | 16-03-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.46% | 43 M€ | +3.07% | - | |
2.34% | 18 M€ | +7.01% | - | |
2.13% | 6 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 95.56 | +0.43% | 4 007 449 |
24-03-27 | 95.15 | +1.85% | 3,656,907 |
24-03-26 | 93.42 | +0.28% | 2,750,083 |
24-03-25 | 93.16 | -0.67% | 2,497,213 |
24-03-22 | 93.79 | -0.94% | 2,452,996 |
Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.79% | 57.27B | |
+9.15% | 221B | |
+18.60% | 142B | |
+18.70% | 101B | |
+7.38% | 68.07B | |
-2.49% | 47.42B | |
+6.00% | 43.19B | |
+16.80% | 41.12B | |
+14.13% | 28.84B | |
-0.40% | 22.04B |